Brentuximab vedotin in cutaneous T-Cell lymphoma: emerging evidence and therapeutic insights for CD30-negative and CD30-low disease
{{output}}
Background: Cutaneous T-cell lymphomas (CTCL) are rare, heterogeneous non-Hodgkin lymphomas primarily involving the skin and are associated with poor outcomes in advanced disease. CD30 expression varies across CTCL subtypes and s... ...
